Citadel Advisors’s Theriva Biologics TOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.6K Buy
+36,018
New +$15.6K ﹤0.01% 5654
2024
Q2
Sell
-987
Closed -$11.6K 6816
2024
Q1
$11.6K Sell
987
-1,331
-57% -$15.6K ﹤0.01% 5660
2023
Q4
$24.9K Buy
+2,318
New +$24.9K ﹤0.01% 5321
2023
Q2
Sell
-824
Closed -$14.4K 6485
2023
Q1
$14.4K Buy
+824
New +$14.4K ﹤0.01% 5458
2022
Q4
Sell
-2,243
Closed -$55K 6716
2022
Q3
$55K Buy
+2,243
New +$55K ﹤0.01% 5285
2022
Q1
Sell
-1,112
Closed -$76K 7118
2021
Q4
$76K Buy
1,112
+937
+535% +$64K ﹤0.01% 6029
2021
Q3
$20K Buy
175
+133
+317% +$15.2K ﹤0.01% 6282
2021
Q2
$6K Sell
42
-2,114
-98% -$302K ﹤0.01% 6342
2021
Q1
$368K Buy
+2,156
New +$368K ﹤0.01% 4845
2019
Q2
Sell
-102
Closed -$17K 5104
2019
Q1
$17K Buy
102
+47
+85% +$7.83K ﹤0.01% 4420
2018
Q4
$8K Buy
+55
New +$8K ﹤0.01% 4427
2018
Q3
Sell
-13
Closed -$28K 4716
2018
Q2
$28K Buy
+13
New +$28K ﹤0.01% 3999
2018
Q1
Sell
-28
Closed -$122K 4413
2017
Q4
$122K Buy
28
+21
+300% +$91.5K ﹤0.01% 3490
2017
Q3
$55K Buy
+7
New +$55K ﹤0.01% 3399
2016
Q3
Sell
-2
Closed -$39K 4074
2016
Q2
$39K Hold
2
﹤0.01% 3090
2016
Q1
$32K Buy
+2
New +$32K ﹤0.01% 3073
2015
Q4
Sell
-5
Closed -$95K 4285
2015
Q3
$95K Sell
5
-5
-50% -$95K ﹤0.01% 3397
2015
Q2
$243K Buy
+10
New +$243K ﹤0.01% 2948
2015
Q1
Hold
0
-$1K 4032
2014
Q4
Sell
-2
Closed -$28K 3788
2014
Q3
$28K Hold
2
﹤0.01% 3244
2014
Q2
$33K Sell
2
-3
-60% -$49.5K ﹤0.01% 3192
2014
Q1
$105K Buy
+5
New +$105K ﹤0.01% 3051